GE Healthcare will donate $1 million in ultrasound and monitoring equipment to Ukraine as the ongoing war continues to take a toll on the country's healthcare system.
The company will donate displays to monitor adult and pediatric patient vital signs at bedside in general ward and intensive care units as well as both handheld and stationary ultrasound devices for emergency care, obstetrics, and gynecology, the company said.
The $1 million donation is in addition to a $4 million equipment donation the company made in March 2022 and a GE Foundation donation of $500,000 to the International Rescue Committee and Airlink to provide immediate and long-term relief to neighboring countries that are welcoming refugees from Ukraine.
In addition, under a six-month Ukraine refugee support program, GE has offered cost reimbursements and paid time off to employees who have opened their homes to refugees and helped provide necessities such as food, medicine, and clothing. Approximately 360 GE employees have participated in the program, amounting to more than $300,000 in reimbursements, the company said.
In other GE news, the company will highlight the capabilities of its Imaging 360 Platform for Operations at RSNA 2022.
The workload management platform is an option for the company's PACS and integrates with the Helix Radiology Performance Suite, which was developed by Quantum Imaging & Therapeutic Associates. The Imaging 360 Platform for Operations helps optimize radiologist resources across an entire enterprise, according to GE, distributing the workload among the most efficient radiologists in real time.
GE added that based on an impact analysis at Quantum, the Imaging 360 Platform for Operations enabled a 16.7% improvement in turnaround time (TAT), a 20.5% improvement in emergency department TAT, and a 27.7% improvement in inpatient TAT.
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
